DOTmed June 24, 2024
In recent years, healthcare data has emerged as an increasingly valuable asset, with its importance expanding rapidly. In the United States alone, the market for interoperable clinical data is projected to nearly double, reaching $6.2 billion by 2026 from $3.4 billion in 2022. This surge in value reflects the dynamic changes occurring in healthcare, primarily driven by advancements in artificial intelligence and data-driven technologies capable of collecting and processing vast amounts of data.
The ability to achieve this balance is challenged by regulatory frameworks, which have struggled to keep up with rapid technological advancement. Globally, governments are grappling with the complexities of integrating AI into healthcare. For instance, the UK’s Department of Science, Innovation, and Technology is diligently working to...